The University of Oxford has launched a £118M AI vaccine research programme, CoI-AI, with the Ellison Institute, aiming to combat antibiotic resistance through human challenge trials.
Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.
Asymptomatic older patients of COVID-19 are one of the most difficult to identify - now, researchers find that delirium could be an indicator of the virus
Dr Deborah Lee from Dr Fox Online Pharmacy discusses why we need to wear a face covering during the current COVID-19 pandemic, stating the evidence in this illuminating analysis.
Eight days after the Pfizer vaccine results (90% effective) brought collective hope to the world, the Moderna vaccine has proven to be 95% effective at fighting COVID-19.
Yesterday, at 6:45am in the US, the Pfizer vaccine was revealed to be over 90% effective - so when will the successful drug be available for the UK to use?
Abdullah Sabyah, Founder and CEO Rightangled, discusses the need to overhaul the government’s approach to coronavirus testing in schools and explores how home-based private testing can ensure children continue to receive the education they need.
New research from the UBC Sauder School of Business suggests that Republicans are more likely to follow COVID-19 guidelines to protect themselves rather than for their community.
The UK winter lockdown was leaked on Friday night, with a hasty press conference assembled on Saturday - so what are the new rules and why was this introduced so late?
Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
UK Research and Innovation (UKRI) and the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India are launching a joint funding initiative to support the UK-India COVID-19 research collaboration.
